Feed ODTX
OD

Odyssey Therapeutics, Inc. ODTX NASDAQ · Healthcare · United States

$16.96 -7.52% -$1.38

Summary

45 / 100 · Bulios Score

What speaks for it

  • It holds more cash than debt: $80.6M against $23.5M.

What to watch

None of the indicators we track raises a caution right now.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Valuation in detail

Is it growing?

Revenue (USD)

  • Analyst estimate

For the next fiscal year analysts expect revenue to grow by 0.0%.

Growth in detail

Does it make money?

Over the last 12 months it made a loss of $177.6M.

Profitability in detail

Is it financially healthy?

Yes

Over the last 12 months it spent more cash than it brought in. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $36.6 is 116% above today's price. 100% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy